• Aesthetic Surgery Journal

Welcome to ASAPS

The Medical Professionals section of the American Society for Aesthetic Plastic Surgery (ASAPS) website is designed to provide physicians with essential information about ASAPS continuing medical education, products and services, and participation as an Active Member, International Active Member, Candidate/International Candidate, or plastic surgery resident/fellow.

ASAPS Active Membership is restricted to physicians certified by the American Board of Plastic Surgery, or certified in plastic surgery by the Royal College of Physicians and Surgeons of Canada, who also meet other specific qualifications for continuing medical education and experience in aesthetic surgery. International Active Members must meet high standards applicable within their respective countries.

Gluteal Fat Grafting Safety Advisory

»  July 2018 – Updated Warning to Surgeons Performing Fat Grafting to the Buttocks
»  Multi-Society Gluteal Fat Grafting Task Force issues safety advisory urging practitioners to reevaluate technique

Breast Implant-Associated ALCL

ASAPS is committed to patient safety, advancing the quality of care, and practicing medicine based upon the best available scientific evidence on breast implants. We have issued joint statements with the American Society of Plastic Surgeons (ASPS) regarding Breast Implant-Associated ALCL (BIA-ALCL).

»  BIA-ALCL Advisory Update [as of July 2018]
»  BIA-ALCL Frequently Asked Questions [as of January 2018]
»  What’s Your Micromort? A Patient-Oriented Analysis of BIA-ALCL
»  VIDEO: What’s Your Micromort? A Patient-Oriented Analysis of BIA-ALCL
»  BIA-ALCL By the numbers, and what they mean
»  Member FAQs: Latest Information on ALCL
»  Office Staff FAQs
»  March 2017 Statement
»  “BEST PRACTICES” BREAST IMPLANT ASSOCIATED ALCL
»  January 2017 Statement
»  July 2016 Statement

Participate in an BIA-ALCL study!

ASAPS’ research funding arm, the Aesthetic Surgery Education and Research Foundation (ASERF), provided a grant to Dr. Marshall Kadin to study the Pathogenesis of BIA-ALCL. His studies have shown that the tumor cells in BIA-ALCL tissues produce IL-13 associated with allergic inflammation, and IgE bound to mast cells which activates them to release Prostaglandin D2 (PGD2) that attracts eosinophils found in BIA-ALCL. He now proposes to measure IL-13, IgE, PGD2 and CD30 to develop a muliparameter test to discriminate benign from malignant seromas in a small amount of seroma fluid. Contributors will recognized in publications.

He requests de-identified samples of late seromas be sent by FedEx first overnight delivery to his lab at Roger Williams Medical Center, Dermatology Research, 825 Chalkstone Ave, Providence RI, phone number 401-447-0067. Bill to receiver using account number 1176-1315-1.

Three forms for submission of specimens are required and appear on the links below: (1) Surgeon Observation form (2) Patient Consent Form (3) Sample Collection form

» Surgeon Observation Form
» Patient Consent Form
» Sample Collection Form

Reminder – same day/next day shipment of specimens for testing via FedEx is critical for accurate test results.

Copyright © 2009-2018 ASAPS. All Rights Reserved.